ChinaAMC Hang Seng Hong Kong Biotech Index ETF (03069.HK) Falls 1.57%, AUM Reaches HKD 2.572 Billion

NewTimeSpace News: As of 14:15 on September 9, ChinaAMC Hang Seng Hong Kong Biotech Index ETF (03069.HK) stood at HKD 15.660, down 1.57%. The ETF opened at HKD 15.890, with the latest net asset value (NAV) at HKD 15.955, a discount of 0.28%, a 52-week high of HKD 18.570, a 52-week low of HKD 11.690, a turnover of approximately HKD 45.9391 million, and assets under management of approximately HKD 2.572 billion.

ChinaAMC Hang Seng Hong Kong Biotech Index ETF (03069.HK) closely tracks the Hang Seng Hong Kong Listed Biotech Index. The manager of the fund is China Asset Management (Hong Kong) Limited. The investment objective is to provide investment returns closely tracking the performance of the Hang Seng Hong Kong Listed Biotech Index (the "Index") before deduction of fees and expenses.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.